China
6 Vaccines Approved for Use in China
Protein Subunit
Anhui Zhifei Longcom
Zifivax
Approved in 4 countries
20 trials in 5 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Inactivated
Shenzhen Kangtai Biological Products Co
KCONVAC
Approved in 2 countries
7 trials in 1 country
Approval Source: reuters.com
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 91 countries
30 trials in 12 countries
Approval Source: reuters.com
Inactivated
Sinopharm (Wuhan)
Inactivated (Vero Cells)
Approved in 2 countries
9 trials in 7 countries
Approval Source: reuters.com
Inactivated
29 in Clinical Trials in China
Protein Subunit
Anhui Zhifei Longcom
Zifivax
Approved in 4 countries
20 trials in 5 countries
Protein Subunit
Livzon Mabpharm Inc
V-01
7 trials in 3 countries
Protein Subunit
Sinocelltech
SCTV01C
12 trials in 2 countries
Protein Subunit
National Vaccine and Serum Institute
Recombinant SARS-CoV-2 Vaccine (CHO Cell)
Approved in 1 country
3 trials in 2 countries
Protein Subunit
West China Hospital
Recombinant (Sf9 cell)
7 trials in 4 countries
Protein Subunit
Clover
SCB-2019
14 trials in 13 countries
DNA
Inovio
INO-4800
9 trials in 9 countries
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
84 trials in 27 countries
RNA
Walvax
mRNA
4 trials in 3 countries
RNA
Pfizer/BioNTech
BNT162b1
5 trials in 3 countries
Non Replicating Viral Vector
CanSino
Ad5-nCoV-IH
3 trials in 3 countries
Non Replicating Viral Vector
CanSino
Convidecia
Approved in 10 countries
13 trials in 6 countries
Replicating Viral Vector
Wantai
DelNS1-2019-nCoV-RBD-OPT1
5 trials in 3 countries
Inactivated
Shenzhen Kangtai Biological Products Co
KCONVAC
Approved in 2 countries
7 trials in 1 country
Inactivated
Sinopharm (Wuhan)
Inactivated (Vero Cells)
Approved in 2 countries
9 trials in 7 countries
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 91 countries
30 trials in 12 countries
Inactivated
Sinovac
CoronaVac
Approved in 56 countries
37 trials in 9 countries
Protein Subunit
Livzon Pharmaceutical Group Inc
V-01-351/V-01D
Protein Subunit
Shanghai Zerun Biotechnology, Walvax Biotechnology
202-CoV
4 trials in 1 country
RNA
Stemirna Therapeutics Co Ltd
mRNACOVID-19 Vaccine
3 trials in 2 countries
Non Replicating Viral Vector
Shenzhen Geno-Immune Medical Institute
LV-SMENP
2 trials in 1 country
RNA
AIM Vaccine
LVRNA009
2 trials in 1 country
Non Replicating Viral Vector
AMMS
Ad5-nCoV
Replicating Viral Vector
Shenzhen Geno-Immune Medical Institute
Covid-19/aAPC
RNA
CSPC ZhongQi Pharmaceutical Technology
SYS6006
2 trials in 1 country
Inactivated
China National Biotec Group Company Limited
Omicron COVID-19 Vaccine (Vero Cell)
3 trials in 1 country
Inactivated
Sinovac
COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)
Inactivated
Sinovac
COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)
Protein Subunit
National Vaccine and Serum Institute